Effect of high-dose glucocorticoid on adrenal cortex in treatment of thyroid associated ophthalmopathy

Lü Qian,TANG Wei,LIANG Cui,YAN Qun,SONG Yan,ZHANG Bei,YE Fei,FENG Xiaoyun,SUN Liangliang,SHI Yongquan

2013-01-01

Abstract:Objective To evaluate the effect of high-dose glucocorticoid on adrenal cortex in patients with thyroid associated ophthalmopathy (TAO). Methods A total of 48 patients with active severe TAO were divided into intermittent treatment group (n=24) and maintenance treatment group (n=24) by stratified random method. All patients received intravenous infusion of methylprednisolone 500 mg/d for 3 consecutive days as a course of treatment at intervals of 4 weeks (a total of of six courses). In the maintenance group, the patients were treated with oral prednisone in the interim period; the initial dose was 10 mg/d and the drug was gradually reduced and stopped within four weeks. The function of thyroid gland and the levels of related antibodies were examined before treatment. Clinical activity score (CAS) and NOSPECS level were evaluated, and the ocular condition, including exophthalmos, the thickness of extraocular muscles, double vision and intraocular pressure was assessed before treatment, 4 and 24 weeks after treatment. At the same time, the levels of serum cortisol, adrenocorticotropic hormone (ACTH) and 24-hour urinary cortisol were detected. Results There were no significant differences in the function of thyroid gland or the levels of related antibodies between two groups (all P>0.05). Neither were the effective rate of treatment (83.3% in the intermittent treatment group and 87.5% in the maintenance treatment group) at the end of the treatment and recurrence rate (20.0% in the intermittent treatment group and 19.0% in the maintenance treatment group) 4 to 24 weeks after treatment (P>0.05). CAS score, NOSPECS level, exophthalmos, the thickness of extraocular muscles and intraocular pressure were significantly decreased 4 and 24 weeks after treatment as compared with those before treatment (all P<0.05). And intraocular pressure at the end of 24 weeks after treatment was significantly lower than that at 4 weeks after treatment (all P<0.05). Adrenocortical function was normal before treatment and 4 weeks afer treatment. In the maintenance treatment group, the levels of serum cortisol, adrenocorticotropic hormone (ACTH) and 24-hour urinary cortisol were significantly lower than those before treatment and 24 week after treatment (all P<0.05). The incidence of adverse reaction in the maintenance treatment group was significantly higher than that in the intermittent treatment group (85.7% vs. 30.0%, P<0.05). Conclusions High dose methylprednisolone intermittent therapy is effective for thyroid associated ophthalmopathy. The clinical outcomes are not significantly improved in the patiens with oral prednisone in the interval, but there are more adverse effects and the adrenal function is significantly inhibited.